Gossamer Bio announces $250m in funding to advance seralutinib
1 source
·6h ago
← All stories
Gossamer Bio
Pharmaceutical Preparations · US
- HQ
- SAN DIEGO, CA
- Industry
- Pharmaceutical Preparations
- Country
- US
In the news · 1
Recent filings
- 13 Aug 2026 10-Q Q2 2026
Actual SEC filing dates from EDGAR.
More in Healthcare